Skip to main content

Articles

Page 7 of 7

  3. The baseline levels of serum procalcitonin (PCT) have not been determined in patients with end-stage renal disease needing renal replacement therapy. The purpose of the present study is to verify the reference...

    Authors: Koji Ichihara, Toshiaki Tanaka, Satoshi Takahashi, Masanori Matsukawa, Masahiro Yanase, Hiroshi Kitamura and Naoya Masumori

    Citation: Renal Replacement Therapy 2016 2:9

    Content type: Research

    Published on:

  4. Needle insertion pain associated with maintenance hemodialysis (HD) causes considerable stress on HD patients with native arteriovenous fistula. Skin cooling has been suggested to modify pain sensitivity and r...

    Authors: Toshihiro Torato, Masao Iwagami, Hiroshi Kawaguchi, Toshiaki Suzuki, Noriyuki Yamamoto, Shigeki Matsuo, Chiduru Ishikawa, Daisuke Katagiri, Yoshifumi Hamasaki, Norio Hanafusa, Masaomi Nangaku, Tsutomu Sanaka and Eisei Noiri

    Citation: Renal Replacement Therapy 2016 2:6

    Content type: Research

    Published on:

  5. Hemodialysis (HD) patients who are resistant to erythropoiesis-stimulating agents (ESAs) have a higher mortality rate. The aim of this study was to assess the relationship between the time-dependent variabilit...

    Authors: Shunji Shiohira, Ken Tsuchiya, Hiroshi Kataoaka, Masayuki Okazaki, Mizuki Komatsu, Toshiaki Naganuma, Hiroshi Kawaguchi and Kosaku Nitta

    Citation: Renal Replacement Therapy 2016 2:10

    Content type: Research

    Published on:

  7. The goal of the present study was to explore the differences in effects between erythropoiesis-stimulating agent (ESA) types on hemoglobin (Hb) level at the initiation of maintenance dialysis.

    Authors: Takasuke Asakawa, Yasuhiro Komatsu, Ryoichi Ando, Nobuhiko Joki, Yuri Tanaka, Masaki Iwasaki, Hiroki Hase, Masato Ikeda, Daijo Inaguma, Toshifumi Sakaguchi, Toshio Shinoda, Fumihiko Koiwa, Shigeo Negi, Toshihiko Yamaka and Takashi Shigematsu

    Citation: Renal Replacement Therapy 2016 2:12

    Content type: Research

    Published on:

  8. Because hemodialysis therapy cannot be performed without the cannulation of a vascular access, establishing a well-functioning vascular access is crucial. Recently, the number of patients with difficult arteri...

    Authors: Tadashi Kamata, Mayumi Tomita and Noriyuki Iehara

    Citation: Renal Replacement Therapy 2016 2:7

    Content type: Review

    Published on:

  9. Japan has relatively low incidence rates of renal replacement therapy (RRT) for end-stage kidney disease (ESKD) among those aged 0–19 years, but relatively high rates for the older age band. On the other hand,...

    Authors: Minako Wakasugi, Junichiro James Kazama and Ichiei Narita

    Citation: Renal Replacement Therapy 2016 2:5

    Content type: Research

    Published on:

  12. Glycated albumin (GA) has been reported to be a better indicator of glycemic control than hemoglobin A1c (HbA1c) in diabetic hemodialysis (HD) patients.

    Authors: Yuki Tsuruta, Akiko Ichikawa, Kan Kikuchi, Yoshihisa Echida, Takako Onuki and Kosaku Nitta

    Citation: Renal Replacement Therapy 2016 2:3

    Content type: Research

    Published on:

  13. Peritonitis is the main cause of withdrawal from peritoneal dialysis (PD) therapy in Japan. The precise extent of PD-associated peritonitis in Japan has not been investigated since 2005; we aimed to clarify th...

    Authors: Chieko Higuchi, Minoru Ito, Ikuto Masakane and Hiroshi Sakura

    Citation: Renal Replacement Therapy 2016 2:2

    Content type: Research

    Published on:

  14. Perirenal hematomas are most frequently caused by neoplasm, followed by polyarteritis nodosa (PN), but may also be a rare complication of MPA.

    Authors: Yuri Nakashima, Maki Ohura, Toru Mima, Asuka Masumoto, Masaki Ohya, Shigeo Negi and Takashi Shigematsu

    Citation: Renal Replacement Therapy 2015 1:8

    Content type: Case Report

    Published on:

  15. The nutritional status of patients on maintenance hemodialysis (MHD) is a strong predictor of their survival. We assessed the reliability of a protein-energy wasting (PEW) score as a predictor of the survival ...

    Authors: Sonomi Kobayashi, Keiko Suzuki, Mio Ueda, Yoshiko Tanaka and Kosaku Nitta

    Citation: Renal Replacement Therapy 2015 1:1

    Content type: Research

    Published on:

  16. In blood purification therapies for critical care, there are no guidelines for selecting modalities of the treatment or for determining the treatment schedule, treatment time, and operating conditions, such as...

    Authors: Michio Mineshima

    Citation: Renal Replacement Therapy 2015 1:5

    Content type: Review

    Published on:

  17. As a result of the advances in computers, data collection has become easy. The huge amount of data now available through computers is called big data. The characteristics of big data are represented by three V...

    Authors: Eiichiro Kanda

    Citation: Renal Replacement Therapy 2015 1:4

    Content type: Review

    Published on:

  18. There may be an association between the responsiveness to erythropoiesis-stimulating agent (ESA) and the nutritional status on mortality of maintenance hemodialysis (MHD) patients. Therefore, we assessed the a...

    Authors: Masayuki Okazaki, Mizuki Komatsu, Shunji Shiohira, Hiroshi Kataoka, Ken Tsuchiya, Hiroshi Kawaguchi and Kosaku Nitta

    Citation: Renal Replacement Therapy 2015 1:7

    Content type: Research

    Published on:

  19. Only 4 % of hemodialysis (HD) patients survive over 25 years after their initiation of HD even in Japan. To elucidate their clinical characteristics, we investigated their lifestyle and genetic factor. TT geno...

    Authors: Kaori Sakamoto, Yoshihiko Kanno, Mami Hiraoka, Matsuhiko Hayashi, Yoshiko Kontai and Yasuo Kagawa

    Citation: Renal Replacement Therapy 2015 1:6

    Content type: Research

    Published on:

  20. L-carnitine is an essential compound that facilitates the transport of long-chain fatty acid across the inner mitochondrial membrane for β-oxidation. However, the effect of L-carnitine supplementation remains ...

    Authors: Haruki Sada, Akihiko Kato, Ryo Sumimoto, Hiromitsu Ohmori and Hideki Ohdan

    Citation: Renal Replacement Therapy 2015 1:3

    Content type: Research

    Published on:

Submit manuscript

Annual Journal Metrics

  • Speed
    37.6 days to first decision for reviewed manuscripts only
    28.5 days to first decision for all manuscripts
    118.9 days from submission to acceptance
    25 days from acceptance to publication

    Usage 
    210,852 Downloads
    33 Altmetric mentions

Renal Replacement Therapy

ISSN: 2059-1381

Contact us